- Home
- SMSI vs CLGN Comparison
SMSI vs CLGN Comparison
Compare SMSI & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- CLGN
- Stock Information
- Founded
- SMSI 1982
- CLGN 2004
- Country
- SMSI United States
- CLGN Israel
- Employees
- SMSI N/A
- CLGN N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- CLGN Industrial Specialties
- Sector
- SMSI Technology
- CLGN Health Care
- Exchange
- SMSI Nasdaq
- CLGN Nasdaq
- Market Cap
- SMSI 16.7M
- CLGN 19.1M
- IPO Year
- SMSI 1995
- CLGN N/A
- Fundamental
- Price
- SMSI $0.89
- CLGN $2.01
- Analyst Decision
- SMSI Strong Buy
- CLGN Strong Buy
- Analyst Count
- SMSI 1
- CLGN 2
- Target Price
- SMSI $5.00
- CLGN $11.50
- AVG Volume (30 Days)
- SMSI 293.0K
- CLGN 72.3K
- Earning Date
- SMSI 07-31-2025
- CLGN 08-19-2025
- Dividend Yield
- SMSI N/A
- CLGN N/A
- EPS Growth
- SMSI N/A
- CLGN N/A
- EPS
- SMSI N/A
- CLGN N/A
- Revenue
- SMSI $19,378,000.00
- CLGN $2,472,000.00
- Revenue This Year
- SMSI $10.12
- CLGN $1,999.42
- Revenue Next Year
- SMSI $63.12
- CLGN $69.81
- P/E Ratio
- SMSI N/A
- CLGN N/A
- Revenue Growth
- SMSI N/A
- CLGN N/A
- 52 Week Low
- SMSI $0.52
- CLGN $1.31
- 52 Week High
- SMSI $2.57
- CLGN $5.45
- Technical
- Relative Strength Index (RSI)
- SMSI 47.81
- CLGN 55.94
- Support Level
- SMSI $0.87
- CLGN $1.70
- Resistance Level
- SMSI $1.30
- CLGN $1.86
- Average True Range (ATR)
- SMSI 0.10
- CLGN 0.11
- MACD
- SMSI 0.00
- CLGN 0.08
- Stochastic Oscillator
- SMSI 20.94
- CLGN 85.09
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.